High-Risk IV Medications in Special Patient Populations by Sandra Kane-Gill and Joseph Dasta
English | 2011-06-29 | ISBN: 0857296051 | PDF | 160 pages | 2 MB
Critically ill patients are at risk for a higher frequency and severity of adverse drug events (ADEs), and special patient populations of the critically ill – requiring for instance individualized dosing due to non-average weight, hepatic or renal dysfunction, extracorporeal circulation devices, advanced age, pharmacogenetic alterations, hemodynamic instability, or therapeutic hypothermia – are particularly challenging.